Sectors
Eagle Nuclear’s First 10-Q, ELEKTROS’s Recycled Releases, and a Uranium Deal
Eagle Nuclear Energy Corp. filed its first 10-Q as a public company on July 20, reporting a $28.1 million cash balance and zero interest-bearing debt. ELEKTROS Inc. put out its fourth press release in eight days that same week, repeating the same 10-to-15-station EV charging plan it has announced without a single signed site since…
CareDx Jumps on Medicare Win, OKYO Pharma Funds Phase 3 Trial
A federal coverage policy that took a year to finalize added more than $200 million to CareDx’s market value in a single trading session. Nothing about the underlying science changed. The paperwork did. Two much smaller names had quieter weeks of their own: one locked in the cash to finish its pivotal trial, the other…
Trump Meeting Fails to Break Clarity Act Deadlock, Strategy Sets BTC Terms
President Trump sat down with senators Thursday to break the Clarity Act’s ethics deadlock. Strategy’s chief executive went on Bloomberg TV and tied the company’s next bitcoin purchase to a preferred stock hitting a price it has not reached since April. Both are still unresolved as this goes to print. Trump-Senate Meeting Ends Without a…
Goliath Expands Bonanza Zone, Revival Gold Hits Mercur Gold
Visible sulfides in a fresh drill core tell an experienced geologist most of what a lab will eventually confirm, weeks before the assays arrive. In British Columbia’s Golden Triangle, that visual read alone was enough to extend a known gold zone by 750 metres this week, with the market reacting before a single sample reached…
Orca Bio’s Tregzi Is the First Regulatory T Cell Therapy Ever Approved
The FDA approved Orca Bio’s Tregzi on June 30, making it the first regulatory T cell-based immunotherapy to receive clearance in the agency’s history. The next morning it expanded Casgevy’s label to children as young as two, placing a potentially curative CRISPR gene therapy within reach of approximately 5,500 additional American children with sickle cell…
AI Power Crunch Drives Two Cleantech Companies to On-Site Power Solutions
The US electric grid cannot connect new power demand fast enough. The interconnection queue for new generation and large load projects in North America now runs to more than five years on average. AI data centers need power on a timeline measured in months, not years. That gap between what the grid can deliver and…
Bending Spoons Surges 40% on Nasdaq Debut in 2026 Biggest Software IPO
The second quarter ended on a high note and then handed the calendar to July. Q2 2026 was the best quarter for major indexes since 2020. The Nasdaq gained 21 percent. The Russell 2000 climbed 22 percent for its best first half since 1991. The S&P 500 closed Q2 up nearly 15 percent. The Dow…
Hudbay Closes Arizona Sonoran to Build Third-Largest North American Copper Hub
Copper futures are up approximately 8% year to date. Gold is down 7% from the same starting point, and down $1,380 from its January all-time record at $5,405. Hudbay Minerals closed its acquisition of Arizona Sonoran Copper on June 24, creating what it describes as the third-largest copper district in North America. On June 23,…
PJM Hit a 20-Year Demand Record as Wind and Solar Subsidies Expire
The One Big Beautiful Bill’s construction-start deadline for wind and solar projects expired at midnight on July 4, 2026, closing 35 years of federal subsidy support for new clean energy capacity. The same weekend, PJM Interconnection — the largest power grid in the United States, serving 67 million people — triggered its third federal emergency…
Satellos Bioscience Earns Third FDA Designation for Duchenne Drug SAT-3247
The FDA approved 44 novel therapies in the first half of 2026, including 26 in the final six months alone. BioPharma Dive described it as an acceleration, driven partly by a White House-directed overhaul aimed at restoring more traditional leadership to the agency. The pace matters for small companies whose entire business model rests on…
